ProfileGDS4132 / 210244_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 81% 81% 76% 77% 78% 77% 76% 76% 75% 75% 74% 69% 75% 80% 69% 68% 74% 74% 75% 74% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101275.66381
GSM201543Muscle PCOS pioglitazone 121266.89981
GSM201544Muscle PCOS pioglitazone 161257.16676
GSM201545Muscle PCOS pioglitazone 201266.41377
GSM201829Muscle PCOS pioglitazone 231266.5378
GSM201830Muscle PCOS pioglitazon 251254.31977
GSM201831Muscle PCOS pioglitazone 271255.1776
GSM201832Muscle PCOS pioglitazone 31233.39376
GSM201833Muscle PCOS pioglitazone 41227.51375
GSM201834Muscle PCOS pioglitazone 81238.53575
GSM201835Muscle PCOS after pioglitazone 102231.14174
GSM201836Muscle PCOS after pioglitazone 122198.85969
GSM201837Muscle PCOS after pioglitazone 162221.75375
GSM201838Muscle PCOS after pioglitazone 202290.48480
GSM201839Muscle PCOS after pioglitazone 232203.61969
GSM201840Muscle PCOS after pioglitazone 252201.38968
GSM201841Muscle PCOS after pioglitazone 272222.92774
GSM201842Muscle PCOS after pioglitazone 32203.74874
GSM201843Muscle PCOS after pioglitazone 42232.90275
GSM201844Muscle PCOS after pioglitazone 82238.56374